On October 12, 2023 OmniAb, Inc. (Nasdaq: OABI) reported it will hold a virtual Research & Technology event on Thursday, November 9 beginning at 11:00 a.m. Eastern time (Press release, OmniAb, OCT 12, 2023, View Source;Technology-Virtual-Event-on-November-9/default.aspx [SID1234635894]). The event is expected to last approximately two hours and will include a review of the company’s latest technology offerings and financial results for the three and nine months ended September 30, 2023, which will be announced earlier that morning.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Matt Foehr, Chief Executive Officer, will be joined by members of OmniAb’s senior management team, with a Q&A session to follow management’s presentations.

The webcast and replay, including audio, video and presentation slides, will be available on the Investors portion of OmniAb’s website. Additional information about speakers and their presentations, as well as instructions about how to participate will be announced at a later date.